Insider · CIK 0001339498
Adam R Craig
Files at XFOR (X4 Pharmaceuticals, Inc). First filing Oct 27, 2025, latest Oct 27, 2025.
Adam R Craig files SEC Form 4 as chair and director at XFOR (X4 Pharmaceuticals, Inc). Since Oct 27, 2025, Adam R Craig has reported 1 open-market buy worth $250k and 0 open-market sells worth $0, the latest filed on Oct 27, 2025.
A track record needs three past buys with six months of prices behind them; Adam R Craig has 0, so none is measured yet.
The newest scored trade: bought $250k of XFOR on Oct 23, 2025, filed Oct 27, 2025, scored 47 (moderate). In the last 12 months: 1 buy worth $250k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XFOR: X4 Pharmaceuticals, Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | XFORbuy X4 Pharmaceuticals, Inc | $250k 86,206 shares | +30% | +118% from low-87% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Stock Option (right to buy)derivative | +2,329,154 | $0.00 | $0 | 2,329,154 | Oct 31, 2025 |
| Oct 23, 2025 | XFOR X4 Pharmaceuticals, Inc | POpen-market purchase Common Stock | +86,206 | $2.90 | $250k | 376,087 | Oct 27, 2025 |
| Aug 14, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Common Stock | +289,881 | $0.00 | $0 | 289,881 | Aug 14, 2025 |
| Aug 12, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Stock Option (right to buy)derivative | +1,609,873 | $0.00 | $0 | 1,609,873 | Aug 14, 2025 |
| Aug 14, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Stock Option (right to buy)derivative | +529,201 | $0.00 | $0 | 529,201 | Aug 14, 2025 |
Questions about Adam R Craig
Answered from the filings on this page, as of the latest one.
Is Adam R Craig buying or selling?
In the last 12 months Adam R Craig reported 1 open-market buy worth $250k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $250k of XFOR on Oct 23, 2025. Grants, option exercises and tax withholding are not counted.
How did Adam R Craig's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam R Craig has 0.
Where does Adam R Craig file Form 4?
Adam R Craig has filed Form 4 at XFOR (X4 Pharmaceuticals, Inc) as Executive Chairman. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.